查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585678

生物技术设备市场：按产品、最终用户划分 - 2025-2030 年全球预测

Biotechnology Instrumentation Market by Product (Bioreactors, Centrifuges, Electrophoresis), End-User (Biotechnology & Biopharmaceutical Companies, Clinical Research Organizations (CROs), Government & Academic Institutes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物技术设备市场价值为241.9亿美元，预计2024年将达到264.9亿美元，复合年增长率为9.84%，到2030年将达到466.7亿美元。

生物技术设备市场包括生物技术研究、开发和应用所需的各种设备和工具。其中包括基因组学、蛋白质组学、细胞生物学和诊断测试设备。医疗保健、製药和农业领域对先进技术的需求不断增长，以解决疾病诊断、药物发现和基因改造等复杂的生物挑战，从而推动了对这些设备的需求。生物技术设备用于多种应用，包括定序、成像、层析法和光谱学，最终用途包括医学研究机构、製药公司和实验室。

主要市场统计
基准年[2023] 241.9亿美元
预测年份 [2024] 264.9亿美元
预测年份 [2030] 466.7亿美元
复合年增长率（%） 9.84%

市场成长受到分子生物学技术进步、生物技术研究资金增加以及个人化医疗需求不断增长等因素的影响。新的商机在于开发经济高效、可携式、高通量的设备以及人工智慧和机器学习的整合以提高资料分析能力。此外，由于一些生物製药的专利到期，支持生物製药和生物相似药开发的设备市场正在扩大。

该市场面临的挑战包括与先进设备相关的高成本、复杂的法规环境以及需要高技能人员来操作这些复杂设备。此外，技术创新的快速步伐意味着现有设备很快就会过时，并且存在过时的风险。

设备小型化、实验室晶片技术开发以及生物感测器灵敏度和特异性的改进等领域正在创新。专注于降低设备成本以及提高生物技术检测的准确性和速度的研究提供了进一步的成长机会。

生物技术设备市场充满活力且竞争激烈，其特点是不断进步并重视研究和开发。能够驾驭监管环境、响应不断变化的最终用户需求并利用技术创新的公司，就能够充分利用成长潜力并保持其市场地位。

市场动态：揭示快速发展的生物技术设备市场的关键市场洞察

供需的动态交互作用正在改变生物技术设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 疾病持续增加，需有效治疗
    • 扩大携带式照护现场诊断设备的采用
    • 改善各国的医疗保健支出和基础设施
  • 市场限制因素
    • 引进生技设备的初始成本较高
  • 市场机会
    • 实验室自动化设备的进步
    • 增加对基因组研究计划和新兴企业的投资
  • 市场挑战
    • 严格的监管要求和检验流程

波特五力：驾驭生技设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解生物技术设备市场的外部影响

外部宏观环境因素在塑造生物技术设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解生物技术设备市场的竞争格局

对生物技术设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物技术设备市场供应商的绩效评估

FPNV定位矩阵是评估生物技术设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划生物技术设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，生物技术设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 疾病盛行率持续增加，需要有效的治疗方法
      • 越来越多地采用可携式照护现场诊断设备
      • 改善整个经济的医疗保健支出和基础设施
    • 抑制因素
      • 引进生技设备的初始成本较高
    • 机会
      • 实验室自动化设备的进步
      • 对基因组研究计划和Start-Ups的新投资
    • 任务
      • 严格的监管要求和检验流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物技术设备市场：副产品

  • 反应器
  • 离心机
  • 电泳
  • 免疫检测
  • 培养箱
  • 液相层析法
  • 质谱分析
  • 次世代定序
  • 光强度

第七章生物技术设备市场：依最终用户分类

  • 生物技术和生物製药公司
  • 临床研究组织（CRO）
  • 政府和学术机构

第八章美洲生物技术设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太生物技术设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲生技设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alcon Scientific
  • Azenta Life Sciences
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Endress+Hauser Group Services AG
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • HORIBA, Ltd.
  • Hudson Robotics
  • Illumina, Inc.
  • JASCO
  • Lumentum Holdings Inc.
  • Merck KGaA
  • Oxford Nanopore Technologies PLC
  • PerkinElmer US LLC
  • Qiagen GmbH
  • Quest Diagnostics Incorporated
  • Sartorius AG
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Product Code: MRR-521BAA36EA70

The Biotechnology Instrumentation Market was valued at USD 24.19 billion in 2023, expected to reach USD 26.49 billion in 2024, and is projected to grow at a CAGR of 9.84%, to USD 46.67 billion by 2030.

The biotechnology instrumentation market encompasses a wide array of devices and tools essential for the research, development, and application of biotechnology. These include instruments for genomics, proteomics, cell biology, and diagnostic testing. The necessity of these instruments stems from the growing demand for advanced technologies in healthcare, pharmaceuticals, and agriculture to address complex biological challenges, such as disease diagnosis, drug discovery, and genetic modification. Biotech instruments are utilized in various applications, such as sequencing, imaging, chromatography, and spectroscopy, with end-use in medical research institutions, pharmaceutical companies, and laboratories.

KEY MARKET STATISTICS
Base Year [2023] USD 24.19 billion
Estimated Year [2024] USD 26.49 billion
Forecast Year [2030] USD 46.67 billion
CAGR (%) 9.84%

Market growth is influenced by factors such as advancements in molecular biology techniques, increased funding for biotech research, and the rising demand for personalized medicine. Emerging opportunities lie in the development of cost-effective, portable, and high-throughput devices, as well as integrating AI and machine learning to enhance data analysis capabilities. There is also a growing market for instruments that cater to the development of biologics and biosimilars, driven by the expiration of patents for several biologic drugs.

Challenges in the market include high costs associated with advanced instrumentation, the intricate regulatory environment, and the need for highly skilled personnel to operate these complex devices. Furthermore, the rapid pace of technological change can outdate existing instruments quickly, posing a risk of obsolescence.

Innovation is ripe in fields such as miniaturization of devices, development of lab-on-a-chip technologies, and enhancement of biosensor sensitivity and specificity. Research focusing on reducing instrument costs and improving the accuracy and speed of biotechnological assays offers further growth opportunities.

The biotech instrumentation market is dynamic and competitive, characterized by continuous advancements and a strong emphasis on research and development. Companies that can navigate regulatory landscapes, cater to evolving end-user demands, and leverage technological innovations are well-positioned to capitalize on growth potential and sustain their market relevance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotechnology Instrumentation Market

The Biotechnology Instrumentation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Continuous rise in prevalence of diseases and need for effective treatments
    • Growing adoption of portable point-of-care diagnostic devices
    • Improved healthcare spending and infrastructure across economies
  • Market Restraints
    • Initial high costs associated with implementation of biotechnology instruments
  • Market Opportunities
    • Growing advancements in lab automation instruments
    • Emerging investments in genomic research projects and startups
  • Market Challenges
    • Stringent regulatory requirements and validation processes

Porter's Five Forces: A Strategic Tool for Navigating the Biotechnology Instrumentation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotechnology Instrumentation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotechnology Instrumentation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotechnology Instrumentation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotechnology Instrumentation Market

A detailed market share analysis in the Biotechnology Instrumentation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotechnology Instrumentation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotechnology Instrumentation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotechnology Instrumentation Market

A strategic analysis of the Biotechnology Instrumentation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Instrumentation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alcon Scientific, Azenta Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Bruker Corporation, Danaher Corporation, Endress+Hauser Group Services AG, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., HORIBA, Ltd., Hudson Robotics, Illumina, Inc., JASCO, Lumentum Holdings Inc., Merck KGaA, Oxford Nanopore Technologies PLC, PerkinElmer U.S. LLC, Qiagen GmbH, Quest Diagnostics Incorporated, Sartorius AG, Shimadzu Corporation, Siemens Healthcare GmbH, Tecan Trading AG, Thermo Fisher Scientific Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biotechnology Instrumentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bioreactors, Centrifuges, Electrophoresis, Immunoassay, Incubators, Liquid Chromatography, Mass Spectrometry, Next Generation Sequencing, and Spectrophotometers.
  • Based on End-User, market is studied across Biotechnology & Biopharmaceutical Companies, Clinical Research Organizations (CROs), and Government & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Continuous rise in prevalence of diseases and need for effective treatments
      • 5.1.1.2. Growing adoption of portable point-of-care diagnostic devices
      • 5.1.1.3. Improved healthcare spending and infrastructure across economies
    • 5.1.2. Restraints
      • 5.1.2.1. Initial high costs associated with implementation of biotechnology instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advancements in lab automation instruments
      • 5.1.3.2. Emerging investments in genomic research projects and startups
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements and validation processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biotechnology Instrumentation Market, by Product

  • 6.1. Introduction
  • 6.2. Bioreactors
  • 6.3. Centrifuges
  • 6.4. Electrophoresis
  • 6.5. Immunoassay
  • 6.6. Incubators
  • 6.7. Liquid Chromatography
  • 6.8. Mass Spectrometry
  • 6.9. Next Generation Sequencing
  • 6.10. Spectrophotometers

7. Biotechnology Instrumentation Market, by End-User

  • 7.1. Introduction
  • 7.2. Biotechnology & Biopharmaceutical Companies
  • 7.3. Clinical Research Organizations (CROs)
  • 7.4. Government & Academic Institutes

8. Americas Biotechnology Instrumentation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biotechnology Instrumentation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Instrumentation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Alcon Scientific
  • 4. Azenta Life Sciences
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. bioMerieux SA
  • 8. Bruker Corporation
  • 9. Danaher Corporation
  • 10. Endress+Hauser Group Services AG
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. GE HealthCare Technologies Inc.
  • 13. HORIBA, Ltd.
  • 14. Hudson Robotics
  • 15. Illumina, Inc.
  • 16. JASCO
  • 17. Lumentum Holdings Inc.
  • 18. Merck KGaA
  • 19. Oxford Nanopore Technologies PLC
  • 20. PerkinElmer U.S. LLC
  • 21. Qiagen GmbH
  • 22. Quest Diagnostics Incorporated
  • 23. Sartorius AG
  • 24. Shimadzu Corporation
  • 25. Siemens Healthcare GmbH
  • 26. Tecan Trading AG
  • 27. Thermo Fisher Scientific Inc.
  • 28. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. BIOTECHNOLOGY INSTRUMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOTECHNOLOGY INSTRUMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOTECHNOLOGY INSTRUMENTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROPHOTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. INDIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. INDONESIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. JAPAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MALAYSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. PHILIPPINES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. SINGAPORE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. SOUTH KOREA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. TAIWAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. THAILAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. VIETNAM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. DENMARK BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. EGYPT BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. FINLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. FRANCE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. GERMANY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ISRAEL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ITALY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. NETHERLANDS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. NIGERIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. NORWAY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. POLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. QATAR BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. RUSSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SAUDI ARABIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SPAIN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SWEDEN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. SWITZERLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. TURKEY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED ARAB EMIRATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED KINGDOM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 108. BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2023